Tudan C, Jackson J K, Charlton L, Pelech S L, Sahl B, Burt H M
Department of Medicine, University of British Columbia, Biomedical Research Centre, Kinetek Biotechnology Corporation, Suite 500, 520 West 6th Avenue, Vancouver, BC, V5Z 1A1, Canada.
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):531-7. doi: 10.1042/bj3310531.
Phosphatidylinositol 3-kinase (PI 3-kinase) has been shown previously to be a central enzyme in crystal-induced neutrophil activation. Since activation of the 70 kDa S6 kinase (p70S6K) has been shown to be dependent on PI 3-kinase activation in mammalian cells, and since the former is a key enzyme in the transmission of signals to the cell nucleus, activation of p70(S6K) was investigated in crystal-stimulated neutrophils. Cytosolic fractions from calcium pyrophosphate dihydrate (CPPD)-crystal-activated neutrophils were separated by Mono Q chromatography and analysed for phosphotransferase activity using a range of substrates and probed by Western analysis using antibodies to p70(S6K) and mitogen-activated protein kinase (MAP kinase). CPPD crystals induced a robust, transient activation (peak activity at 2 min) of p70(S6K) that was fully inhibited by pretreatment with rapamycin. This is the first report of the activation of p70(S6K) in neutrophil signal transduction pathways induced by an agonist. This crystal-induced activation of p70(S6K) could also be inhibited by a protein kinase C (PKC) inhibitor (Compound 3), but not by the PI 3-kinase inhibitor wortmannin. CPPD crystals also activated the ERK1 and ERK2 forms of MAP kinase (wortmannin insensitive), PKC (Compound 3 sensitive) and protein kinase B (wortmannin sensitive) in neutrophils. These data suggest that activation of p70(S6K) may proceed through a PI 3-kinase- and protein kinase B-independent but PKC-dependent pathway in crystal-activated neutrophils.
磷脂酰肌醇3激酶(PI 3激酶)先前已被证明是晶体诱导的中性粒细胞激活中的一种核心酶。由于已表明70 kDa S6激酶(p70S6K)的激活在哺乳动物细胞中依赖于PI 3激酶的激活,并且由于前者是信号传递至细胞核的关键酶,因此研究了晶体刺激的中性粒细胞中p70(S6K)的激活情况。用Mono Q色谱法分离来自二水焦磷酸钙(CPPD)晶体激活的中性粒细胞的胞质部分,使用一系列底物分析其磷酸转移酶活性,并使用针对p70(S6K)和丝裂原活化蛋白激酶(MAP激酶)的抗体进行蛋白质印迹分析。CPPD晶体诱导p70(S6K)产生强烈的瞬时激活(2分钟时达到峰值活性),雷帕霉素预处理可完全抑制这种激活。这是关于激动剂诱导的中性粒细胞信号转导途径中p70(S6K)激活的首次报道。这种晶体诱导的p70(S6K)激活也可被蛋白激酶C(PKC)抑制剂(化合物3)抑制,但不能被PI 3激酶抑制剂渥曼青霉素抑制。CPPD晶体还激活了中性粒细胞中的MAP激酶的ERK1和ERK2形式(渥曼青霉素不敏感)、PKC(化合物3敏感)和蛋白激酶B(渥曼青霉素敏感)。这些数据表明,在晶体激活的中性粒细胞中,p70(S6K)的激活可能通过一条不依赖于PI 3激酶和蛋白激酶B但依赖于PKC的途径进行。